AI in Clinical Trials Webinar
Evaluating AI Responsibly
AI in Clinical Trials
What Trial Sponsors Need to Know to Evaluate AI Responsibly
Artificial intelligence is rapidly entering clinical trial operations, oversight, and compliance workflows. As organizations begin evaluating these technologies, many clinical teams are asking the same question:
What does compliance actually look like in the age of AI?
Recent principles from the FDA and EMA make clear that AI-enabled systems cannot be approached in the same way as traditional software. In regulated clinical environments, compliance now depends not only on functionality, but also on context of use, credibility, governance, human oversight, data stewardship, and lifecycle control.
This webinar is designed to help clinical professionals understand how AI is being applied in clinical trials and what responsible deployment should look like in regulated environments.
The goal is not to turn participants into AI experts. Instead, attendees will gain the foundational knowledge needed to:
Understand how AI is entering clinical workflows
Evaluate AI solutions more confidently
Recognize what regulators expect when AI influences clinical operations
Following the presentation, a panel of early adopters will share what actually happens when organizations begin introducing AI into clinical environments, including barriers encountered, lessons learned, and early operational benefits observed.
Brought to you by
Brought to you by
KH ConferencesOrganizer of AI in Clinical Trials Webinar